Allan Butterfield, a professor of biological chemistry in the University of Kentucky College of Arts & Sciences, has been named among the world’s leading Alzheimer’s disease experts by Expertscape, an online base of biomedical expertise.

Butterfield is among the top 0.007% of scholars worldwide based on authorship of Alzheimer’s-related publications indexed in the PubMed database for the past 10 years. He ranks tenth out of nearly 150,000 scholars worldwide and sixth in the U.S.

The Expertscape rankings use an algorithm to identify the most knowledgeable and experienced physicians, clinicians and researchers across more than 29,000 specific topics. The ranking considers factors such as an article’s recency, publication type, journal impact factor and authorship position.

Butterfield’s National Institutes of Health-funded research focuses on free radical oxidative stress in aging and age-related neurodegenerative disorders, particularly Alzheimer's disease. Throughout his career, he has published nearly 700 papers, with most related to this disease.

“This recognition is really a testament to the tremendously talented students and scholars I’ve had in my lab - as well as the opportunity to collaborate with so many wonderful faculty members here at the University of Kentucky and around the world,” said Butterfield.

Butterfield is the UK Alumni Association Endowed Professor of Biological Chemistry, director of the Redox Metabolism Core of the NCI-designated Markey Cancer Center, and faculty in both the Spinal Cord and Brain Injury Research Center and the Sanders-Brown Center on Aging. He also serves an administrative role as associate vice president for research with responsibilities for centers & institutes and research priority areas within UK Research headed by Vice President for Research Lisa Cassis.